TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 43 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,592,854 | -42.5% | 714,285 | 0.0% | 1.20% | -38.8% |
| Q2 2023 | $6,249,994 | -26.1% | 714,285 | 0.0% | 1.96% | -42.6% |
| Q1 2023 | $8,457,134 | +16.3% | 714,285 | 0.0% | 3.41% | +25.4% |
| Q4 2022 | $7,271,421 | +72.8% | 714,285 | 0.0% | 2.72% | +78.4% |
| Q3 2022 | $4,207,000 | +137.5% | 714,285 | 0.0% | 1.52% | +127.3% |
| Q2 2022 | $1,771,000 | -16.5% | 714,285 | 0.0% | 0.67% | +3.2% |
| Q1 2022 | $2,121,000 | – | 714,285 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |